Proposal & sources
About this proposal
This website is an independent redesign proposal for Carocell Bio. It is not the official Carocell Bio website, it is not operated by the company and it is excluded from search engines.
Independent website redesign proposal for Carocell Bio. Not the official Carocell Bio website.
Sources
Content is based on a verified extraction of the official website (https://carocellbio.com/) dated 13 October 2026, the UK Companies House record and the original logo and figures. Figures and photographs are original website files, reproduced unmodified.
Evidence qualifications
- Cellular and ex vivo biopsy results are company-reported preclinical findings.
- Ethics permission for human tissue research is not approval of a medicine.
- No clinical phase, marketing approval, patient efficacy or safety is claimed.
- Patent and licence references in company material are not independently verified.
Unresolved source discrepancies
- Team: the current homepage lists Anuj Madhok as CFO/CBO; other pages list different or earlier roles.
- Addresses: the current footer (London LBIC / Charleston) differs from the older Contact page (Cheadle / San Antonio).
- Candidates: JEL3108 is linked to eczema in a 2024 article and to IBD on a legacy page, while current pages use JEL0305 (dermatitis) and JEL2603 (IBD).
- Dates: the biopsy news is published 10 Jan 2023 but dated 2022 in the body; Boston Bootcamp header and body dates differ.
- Origin: incorporated 2016 (registry); an older deck refers to 2017.
Privacy
This proposal sets no tracking cookies, runs no analytics and collects no personal data. The official privacy and disclaimer pages currently show a maintenance notice, so their text is not reproduced.
Brand and image use
The Carocell Bio logo, photographs and figures belong to their owners. The official footer asks that the company be contacted before reuse; this permission should be confirmed before any public use of this proposal.